Clinical Trials & Safety Monitoring

Clinical trials and pharmacovigilance are increasingly interconnected, with real-time safety monitoring playing a central role in assessing the long-term effects of new treatments. Recent research has emphasized the integration of real-world data (RWD) and AI-driven analytics to detect adverse drug reactions (ADRs) earlier. By linking clinical trial data with pharmacovigilance databases, researchers can improve post-marketing surveillance and ensure continued drug safety after approval. These advancements are crucial for rapidly identifying emerging safety concerns, enhancing patient protection, and ensuring that newly approved drugs maintain their therapeutic benefit across diverse populations.

    Related Conference of Clinical Trials & Safety Monitoring

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Clinical Trials & Safety Monitoring Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in